Adaptive randomization for balancing over covariates

Wiley Interdisciplinary Reviews: Computational Statistics

Volumn 6, Issue 4, 2014, Pages 288-303

  Hu, Feifang ^a   Hu, Yanqing ^b   Ma, Zhenjun ^c   Rosenberger, William F ^d  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c SANOFI   (France)

^d Krasnow Institute for Advanced Study   (United States)

Author keywords

Clinical trials; Covariate adaptive randomization; Dynamic allocation; Inference

Indexed keywords

EXPERIMENTS; INFORMATION TECHNOLOGY;

CLINICAL TRIAL; COVARIATE-ADAPTIVE RANDOMIZATION; DYNAMIC ALLOCATIONS; EUROPEAN MEDICINES AGENCIES; INFERENCE; RANDOMIZATION TESTS; REGULATORY AGENCIES; THEORETICAL DEVELOPMENT;

RANDOM PROCESSES;

EID: 84903314077     PISSN: 19395108     EISSN: 19390068     Source Type: Journal    
DOI: 10.1002/wics.1309     Document Type: Article

References (96)

1. International Conference on Harmonization (ICH) E9 Expert Working Group. Statistical Principles for Clinical Trials, 1998.
2. Fisher RA. The arrangement of field experiments. J Minist Agric 1926, 33:503-513.
3. Senn S. Testing for baseline balance in clinical trials. Stat Med 1994, 13:1715-1726.
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587.
5. Altman DG. Randomisation in the symphony trial. Lancet 2000, 356:1521-1522.
6. Sleight P, Yusuf S, Pogue J, Tsuyuki R, Diaz R, Probstifield J, Heart Outcomes Prevention Evaluation (HOPE) Study. Blood pressure reduction and cardiovascular risk in the hope study. Lancet 2001, 358:2130-2131.
7. Berger V. Selection Bias and Covariate Imbalances in Randomized Clinical Trials. New York: John Wiley & Sons; 2005.
8. Pocock S, Assmann S, Enos L, Kasten L. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 2002, 21:2917-2930.
9. Committee for Proprietary Medicinal Products: Committee for Proprietary Medicinal Products (CPMP): points to consider on adjustment for baseline covariates. Stat Med 2004, 23:701-709.
10. Green S. Design of randomized trials. Epidemiol Rev 2002, 24:4-11.
11. McEntegart DJ. The pursuit of balance using stratified and dynamic randomization techniques: an overview. Drug Inf J 2003, 37:293-308.
12. Smith RL. Sequential treatment allocation using biased coin designs. J R Stat Soc B 1984, 46:519-543.
13. Kalish LA, Begg CB. Treatment allocation methods in clinical trials: a review. Stat Med 1985, 4:129-144.
14. Rosenberger WF, Sverdlov O. Handling covariates in the design of clinical trials. Stat Sci 2008, 23:404-419.
15. Atkinson AC. Optimum biased-coin designs for sequential treatment allocation with covariate information (with discussion). Stat Med 1999, 18:1741-1752.
16. Rosenberger WF, Lachin JM. Randomization in Clinical Trials: Theory and Practice. New York: John Wiley & Sons; 2002.
17. Efron B. Forcing a sequential experiment to be balanced. Biometrika 1971, 58:403-417.
18. Wei LJ. A class of designs for sequential clinical trials. J Am Stat Assoc 1977, 72:382-386.
19. Soares JF, Wu CFJ. Some restricted randomization rules in sequential designs. Commun Stat Theor M 1982, 12:2017-2034.
20. Smith RL. Properties of biased coin designs in sequential clinical trials. Ann Stat 1984, 12:1018-1034.
21. Chen Y-P. Biased coin design with imbalance intolerance. Commun Stat Stochast Models 1999, 15:953-975.
22. Antognini AB, Giovagnoli A. A new 'biased coin design' for the sequential allocation of two treatments. J R Stat Soc C 2004, 53:651-664.
23. Taves DR. The use of minimization in clinical trials. Contemp Clin Trials 2010, 31:180-184.
24. Pond GR, Tang PA, Welch SA, Chen EX. Trends in the application of dynamic allocation methods in multi-arm cancer clinical trials. Clin Trials 2010, 7:227-234.
25. Committee for Medicinal Products for Human Use (CHMP). Guideline on Adjustment for Baseline Covariates. European Medicines Agency, 2013. Draft.
26. Khan O, Fotheringham S, Wood V, Stimson L, Zhang C, Pezzella F, Duvic M, Kerr DJ, Thangue NBL. Hr23b is a biomarker for tumor sensitivity to hdac inhibitor-based therapy. Proc Natl Acad Sci 2010, 107:6532-6537.
27. Li Y, Sheu CC, Ye Y, Andrade MD, Wang L, Chang SC, Aubry MC, Aakre JA, Allen MS, Chen F, et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 2010, 11:321-330.
28. McIlroy M, McCartan D, Early S, Gaora P, Pennington S, Hill ADK, Young LS. Interaction of developmental transcription factor hoxc11 with steroid receptor coactivator src-1 mediates resistance to endocrine therapy in breast cancer. Cancer Res 2010, 70:1585-1594.
29. Hu F. Statistical issues in trial design and personalized medicine. Clin Invest 2012, 2:121-124.
30. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther 1974, 15:443-453.
31. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975, 31:103-115.
32. Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials. A review. Control Clin Trials 2002, 23:662-674.
33. Ciolino J, Zhao W, Martin R, Palesch Y. Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization. Contemp Clin Trials 2011, 32:250-259.
34. Wei LJ. An application of an urn model to the design of sequential controlled clinical trials. J Am Stat Assoc 1978, 73:559-563.
35. Nordle O, Brantmark B. A self-adjusting randomization plan for allocation of patients into two treatment groups. Clin Pharmacol Ther 1977, 22:825-830.
36. Signorini DF, Leung O, Simes RJ, Beller E, Gebski VJ. Dynamic balanced randomization for clinical trials. Stat Med 1993, 12:2343-2350.
37. Heritier S, Gebski V, Pillai A. Dynamic balancing randomization in controlled clinical trials. Stat Med 2005, 24:3729-3741.
38. Russell D, Hoare ZSJ, Whitaker RH, Whitaker CJ, Russell IT. Generalized method for adaptive randomization in clinical trials. Stat Med 2011, 30:922-934.
39. Hu Y, Hu F. Asymptotic properties of covariate-adaptive randomization. Ann Stat 2012, 40:1794-1815.
40. Lebowitsch J, Ge Y, Young B, Hu F. Generalized multidimensional dynamic allocation method. Stat Med 2012, 31:3537-3544.
41. Zhao W, Hill MD, Palesch Y. Minimal sufficient balance: a new strategy to balance baseline covariates and preserve randomness of treatment allocation. Stat Methods Med Res 2012. Epub ahead of print.
42. Han B, Enas NH, McEntegart D. Randomization by minimization for unbalanced treatment allocation. Stat Med 2009, 28:3329-3346.
43. Kuznetsova OM, Tymofyeyev Y. Preserving the allocation ratio at every allocation with biased coin randomization and minimization in studies with unequal allocation. Stat Med 2012, 31:701-723.
44. Kuznetsova OM, Tymofyeyev Y. Expansion of the modified Zelen's approach randomization and dynamic randomization with partial block supplies at the centers to unequal allocation. Contemp Clin Trials 2011, 32:962-972.
45. Zelen M. The randomization and stratification of patients to clinical trials. J Chronic Dis 1974, 27:365-375.
46. McEntegart D. Blocked randomization. In: D'Agostino R, Sullivan L, Massaro J, eds. Wiley Encyclopedia of Clinical Trials. Hoboken: John Wiley & Sons; 2008.
47. Morrissey M, McEntegart D, Lang M. Randomisation in double-blind multicentre trials with many treatments. Contemp Clin Trials 2010, 31:381-391.
48. Begg BC, Iglewicz B. A treatment allocation procedure for sequential clinical trials. Biometrics 1980, 36:81-90.
49. Atkinson AC. Optimum biased coin designs for sequential clinical trials with prognostic factors. Biometrika 1982, 69:61-67.
50. Zhu H, Hu F, Zhao H. Adaptive clinical trial designs to detect interaction between treatment and a dichotomous biomarker. Can J Stat 2013, 41:525-539.
51. Burman CF. On sequential treatment allocations in clinical trials. PhD Thesis, Chalmers University of Technology, 1996.
52. Hoehler FK. Balancing allocation of subjects in biomedical research: a minimization strategy based on ranks. Comput Biomed Res 1987, 20:209-213.
53. Frane JW. A method of biased coin randomization, its implementation, and its validation. Drug Inf J 1998, 32:423-432.
54. Nishi T, Takaichi A. An extended minimization method to assure similar means of continuous prognostic variables between treatment groups. Jpn J Biom 2003, 24:43-55.
55. Endo A, Fumio N, Hamada C, Yoshimura I. Minimization method for balancing continuous prognostic variables between treatment and control groups using kullback-leibler divergence. Contemp Clin Trials 2006, 27:420-431.
56. Stigsby B, Taves DR. Rank-minimization for balanced assignment of subject in clinical trials. Contemp Clin Trials 2010, 31:147-150.
57. Su Z. Balancing multiple baseline characteristics in randomized clinical trials. Contemp Clin Trials 2011, 32:547-550.
58. Lin Y, Su Z. Balancing continuous and categorical baseline covariates in sequential clinical trials using the area between empirical cumulative distribution functions. Stat Med 2012, 31:1961-1971.
59. Hu Y, Hu F. Balancing treatment allocation over continuous covariates: a new imbalance measure for minimization. J Probab Stat 2012, 2012. doi: 10.1155/2012/842369.
60. Ma Z, Hu F. Balancing continuous covariates based on kernel densities. Contemp Clin Trials 2013, 34:262-269.
61. Xiao L, Yank V, Ma J. Algorithm for balancing both continuous and categorical covariates in randomized controlled trials. Comput Methods Programs Biomed 2012, 108:1185-1190.
62. Taves DR. Rank-minimization with a two-step analysis should replace randomization in clinical trials. J Clin Epidemiol 2012, 65:3-6.
63. Tugwell P, Knottnerus JA, Idzerda L. Should minimization replace randomization in all clinical trials? J Clin Epidemiol 2012, 65:1-2.
64. Kahan BC. Rank minimization with a two-step analysis should not replace randomization in clinical trials. J Clin Epidemiol 2012, 65:808-809.
65. Rosenblatt W. Remarks on some nonparametric estimates of a density function. Ann Math Stat 1956, 27:832-837.
66. Parzen E. On estimation of a probability density function and mode. Ann Math Stat 1962, 33:1065-1076.
67. Simonoff JS. Smoothing Methods in Statistics. New York: Springer-Verlag; 1996.
68. Scott DW. Multivariate Density Estimation: Theory, Practice, and Visualization. New York: John Wiley & Sons; 1992.
69. Antognini AB, Zagoraiou M. The covariate-adaptive biased coin design for balancing clinical trials in the presence of prognostic factors. Biometrika 2011, 98:519-535.
70. Antognini AB, Zagoraiou M. On the almost sure convergence of adaptive allocation procedures. Bernoulli. To appear.
71. Hu F, Zhang LX. On the theory of covariate-adaptive designs. Ann Appl Probab 2014. Submitted.
72. Birkett NJ. Adaptive allocation in randomized controlled trials. Control Clin Trials 1985, 6:146-155.
73. Forsythe AB. Validity and power of tests when groups have been balanced for prognostic factors. Comput Stat Data Anal 1987, 5:193-200.
74. Kahan BC, Morris TP. Improper analysis of trials randomised using stratified blocks or minimisation. Stat Med 2012, 31:328-340.
75. Barbachano Y, Coad DS. Inference following designs which adjust for imbalances in prognostic factors. Clin Trials 2013, 10:540-551.
76. Shao J, Yu X, Zhong B. A theory for testing hypotheses under covariate-adaptive randomization. Biometrika 2010, 97:347-360.
77. Shao J, Yu X. Validity of tests under covariate-adaptive biased coin randomization and generalized linear models. Biometircs, 2013. Epub ahead of print.
78. Ma W, Hu F, Zhang L-X. Testing hypotheses of covariate-adaptive randomized clinical trials. J Am Stat Assoc, 2014.
79. Kuznetsova OM. On the second role of the random element in minimization. Contemp Clin Trials 2010, 31:587-588.
80. Kalish LA, BEGG CB. The impact of treatment allocation procedures on nominal significance levels and bias. Control Clin Trials 1987, 8:121-135.
81. Hasegawa T, Tango T. Permutation test following covariate-adaptive randomization in randomized controlled trials. J Biopharm Stat 2009, 19:106-119.
82. Simon R, Simon NR. Using randomization tests to preserve type i error with response adaptive and covariate adaptive randomization. Stat Probab Lett 2011, 81:767-772.
83. Proschan M, Brittain E, Kammerman L. Minimize the use of minimization with unequal allocation. Biometrics 2011, 67:1135-1141.
84. Kuznetsova OM, Tymofyeyev Y. Shift in re-randomization distribution with conditional randomization test. Pharm Stat 2013, 12:82-91.
85. Han B, Yu M, McEntegart D. Weighted re-randomization tests for minimization with unbalanced allocation. Pharm Stat 2013, 12:243-253.
86. Committee for Medicinal Products for Human Use (CHMP). Concept Paper on the Need to Revise the Points to Consider on Adjustment for Baseline Covariates. European Medicines Agency; 2012.
87. Barbachano Y, Coad DS, Robinson DR. Predictability of designs which adjust for imbalances in prognostic factors. J Stat Plan Infer 2008, 138:756-767.
88. Saghaei M, Saghaei S. Implementation of an open-source customizable minimization program for allocation of patients to parallel groups in clinical trials. J Biomed Eng 2011, 4:734-739.
89. Saghaei S. An overview of randomization and minimization programs for randomized clinical trials. J Med Signals Sens 2011, 1:55-761.
90. Cai HW, Xia JL, Xu D, Gao DH, Yan Y. A generic minimization random allocation and blinding system on web. J Biomed Inform 2006, 39:706-719.
91. Cai HW, Xia JL, Gao DH, Cao XM. Implementation and experience of a web-based allocation system with Pocock and Simons minimization methods. Contemp Clin Trials 2010, 31:510-513.
92. Xiao L, Huang Q, Yank V, Ma J. An easily accessible web-based minimization random allocation system for clinical trials. J Med Internet Res 2013, 15:e139.
93. Hu F, Zhang LX. Asymptotic properties of doubly adaptive biased coin designs for multi-treatment clinical trials. Ann Stat 2004, 32:268-301.
94. Hu F, Zhang LX, He X. Efficient randomized adaptive designs. Ann Stat 2009, 37:2543-2560.
95. Zhang LX, Hu F, Cheung SH, Chan WS. Asymptotic properties of covariate-adjusted response-adaptive designs. Ann Stat 2007, 35:1166-1182.
96. Hu F, Rosenberger WF. The Theory of Response-Adaptive Randomization in Clinical Trials. New York: John Wiley & Sons; 2006.